Strategic Acquisition SignalPath was acquired by Alphabet in September 2021, indicating strong backing and potential for expanded integration with tech giants, which can be leveraged to pitch innovative, scalable solutions to prospects seeking cutting-edge clinical trial management tools.
Growth Investment With an $18M Series B funding round in 2019 dedicated to product development and customer expansion, SignalPath is actively investing in enhancing its platform, presenting opportunities to align with clients interested in advanced and evolving clinical trial software.
Market Positioning SignalPath supports over 2,500 trials across numerous sites and users, establishing itself as a leader in clinical research efficiency, ideal for targeting sponsors and research organizations looking to improve trial management through innovative technology solutions.
Industry Focus Operating in the competitive clinical trial software space with firms like IQVIA and TriNetX, SignalPath offers a specialized, high-growth opportunity for organizations seeking tailored, scalable research site solutions in a rapidly evolving industry.
Tech Infrastructure With a robust tech stack including NoSQL, Angular, and Elasticsearch, SignalPath demonstrates technological sophistication, making it an attractive partner for prospects interested in reliable, scalable, and innovative software platforms for clinical research.
$10B
$100M$250M
$1B$10B
$100M$250M
$25M$50M
$1M
$25M$50M
$100M$250MSignalPath uses 8 technology products and services including WordPress, NoSQL, Selenium, and more. Explore SignalPath's tech stack below.
| SignalPath Email Formats | Percentage |
| First.Last@signalpath.com | 30% |
| FLast@signalpath.com | 20% |
| First.Last@signalpath.com | 30% |
| FLast@signalpath.com | 20% |
Software DevelopmentUnited States51-200 Employees
SignalPath is the premier clinical trial technology partner for research sites and sponsors, focused on improving the ease and efficiency of trial execution and management. Supporting over 2,500 trials across 250 sites and 3,000 active users, SignalPath is the industry standard that addresses key pain points in the conduct of trials. To learn more about SignalPath's site and trial solutions, please visit www.signalpath.com.
Company Overview
Funding & FinancialsSignalPath has raised a total of $18M of funding over 5 rounds. Their latest funding round was raised on Oct 22, 2019 in the amount of $18M.
SignalPath's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsSignalPath has raised a total of $18M of funding over 5 rounds. Their latest funding round was raised on Oct 22, 2019 in the amount of $18M.
SignalPath's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com